{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:32:33Z","timestamp":1759937553201,"version":"3.41.2"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The disparities of hr-HPV infection among races\/ethnicities have not been fully discussed. This study aimed to investigate the difference of hr-HPV infection between Chinese Han and Mongols minority women in Inner Mongolia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Genotyping and histopathology data of Chinese Han and Mongols minority women in Inner Mongolia from Chinese Multi-Center Screening Trial were used to analyze the hr-HPV prevalence, and type-specific distribution in abnormal pathology results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The hr-HPV infection rates of Han women was 15.9% while of Mongols was 21.6% (<jats:italic>P<\/jats:italic> &amp;lt; 0.001). The most prevalent genotypes in Han women were ranked as HPV-16,\u221252,\u221218\/-58,\u221231\/-39, and\u221259 while in Mongols were\u221216,\u221231,\u221258,\u221218 and\u221252. When analyzing the age-specific of hr-HPV infection, two peaks were found at age of 40\u201344 (20.5%) and 55\u201359 (23.5%) years in Han women while three peaks were observed at age of 30\u201334 (22.1%), 45\u201349 (22.9%), and 55\u201359 (31.8%) years, respectively, in Mongols. HPV-16 accounting for 62.5 and 53.8% of the CINII+ in Han and Mongols, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The prevalence of hr-HPV was significantly different between the Han and Mongols minority women in Inner Mongolia, races\/ethnicities background should be taken into consideration for the refinement of cervical cancer screening strategies and vaccine implementation in China.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2022.840879","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T07:32:57Z","timestamp":1653463977000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence of Human Papillomavirus Among Chinese Han and Mongols Minority Women in Inner Mongolia, China: Reflected by Self-Collected Samples in CHIMUST"],"prefix":"10.3389","volume":"10","author":[{"given":"Chunlei","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinfeng","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianzhi","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingran","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruizhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juncui","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxue","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Belinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruifang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob Health."},{"key":"B3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ejogrb.2013.01.012","article-title":"Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central Italy","volume":"168","author":"Sammarco","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1023\/A:1018435522475","article-title":"International incidence rates of invasive cervical cancer after introduction of cytological screening","volume":"8","author":"Gustafsson","year":"1997","journal-title":"Cancer Causes Control."},{"key":"B6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American cancer society, American society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"137","author":"Saslow","year":"2012","journal-title":"Am J Clin Pathol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ygyno.2014.12.022","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"136","author":"Huh","year":"2015","journal-title":"Gynecol Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3322\/caac.21628","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American cancer society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J Clin."},{"key":"B10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S1470-2045(18)30763-0","article-title":"Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial","volume":"20","author":"Polman","year":"2019","journal-title":"Lancet Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e001351","DOI":"10.1136\/bmjgh-2018-001351","article-title":"Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis","volume":"4","author":"Yeh","year":"2019","journal-title":"BMJ Glob Health."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J Infect Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int J Cancer."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s10552-009-9422-z","article-title":"Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18","volume":"20","author":"Chen","year":"2009","journal-title":"Cancer Causes Control."},{"key":"B15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13027-021-00360-9","article-title":"The prevalence and distribution of human papillomavirus among 10,867 Chinese Han women","volume":"16","author":"Guo","year":"2021","journal-title":"Infect Agent Cancer."},{"key":"B16","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.ygyno.2008.01.003","article-title":"The disparity of cervical cancer in diverse populations","volume":"109","author":"Downs","year":"2008","journal-title":"Gynecol Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1097\/LGT.0000000000000239","article-title":"A standard protocol for the colposcopy exam","volume":"20","author":"Belinson","year":"2016","journal-title":"J Low Genit Tract Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/LGT.0000000000000577","article-title":"Evaluation of cobas HPV and SeqHPV assays in the Chinese multicenter screening trial","volume":"25","author":"Du","year":"2021","journal-title":"J Low Genit Tract Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1309\/AJCP9P2KJSXEKCJB","article-title":"Development and validation of a new HPV genotyping assay based on next-generation sequencing","volume":"141","author":"Yi","year":"2014","journal-title":"Am J Clin Pathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/LGT.0000000000000528","article-title":"2019 ASCCP risk-based management consensus guidelines: methods for risk estimation, recommended management, and validation","volume":"24","author":"Cheung","year":"2020","journal-title":"J Low Genit Tract Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jama.2018.7464","article-title":"Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial","volume":"320","author":"Ogilvie","year":"2018","journal-title":"JAMA."},{"key":"B22","doi-asserted-by":"publisher","first-page":"l240","DOI":"10.1136\/bmj.l240","article-title":"Primary cervical screening with high risk human papillomavirus testing: observational study","volume":"364","author":"Rebolj","year":"2019","journal-title":"BMJ."},{"key":"B23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/jmv.24888","article-title":"Prevalence of human papillomavirus infection in women in the autonomous region of inner Mongolia: a population-based study of a Chinese ethnic minority","volume":"90","author":"Wang","year":"2018","journal-title":"J Med Virol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/jmv.24352","article-title":"Ethnic and geographic variations in HPV prevalence and genotype distribution in north-western Yunnan, China","volume":"88","author":"Baloch","year":"2016","journal-title":"J Med Virol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.virol.2013.07.018","article-title":"Human papillomavirus genome variants","volume":"445","author":"Burk","year":"2013","journal-title":"Virology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"djw100","DOI":"10.1093\/jnci\/djw100","article-title":"HPV16 sublineage associations with histology-specific cancer risk using hpv whole-Genome Sequences in 3200 Women","volume":"108","author":"Mirabello","year":"2016","journal-title":"J Natl Cancer Inst."},{"key":"B27","doi-asserted-by":"publisher","first-page":"14813","DOI":"10.1038\/s41598-017-13299-y","article-title":"Prevalence and genotype distribution of human papillomavirus in 961,029 screening tests in southeastern China (Zhejiang Province) between 2011 and 2015","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1002\/cam4.2017","article-title":"The prevalence, trends, and geographical distribution of human papillomavirus infection in China: the pooled analysis of 1.7 million women","volume":"8","author":"Zhu","year":"2019","journal-title":"Cancer Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3322\/caac.21557","article-title":"Cancer screening in the United States, 2019: a review of current American cancer society guidelines and current issues in cancer screening","volume":"69","author":"Smith","year":"2019","journal-title":"CA Cancer J Clin."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1093\/cid\/ciu214","article-title":"HIV\/AIDS epidemic among older adults in China during 2005-2012: results from trend and spatial analysis","volume":"59","author":"Xing","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jclinepi.2021.06.009","article-title":"The prevalence of HR-HPV infection based on self-sampling among women in China exhibited some unique epidemiologic features","volume":"139","author":"Du","year":"2021","journal-title":"J Clin Epidemiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e107573","DOI":"10.1371\/journal.pone.0107573","article-title":"Meta-analysis on prevalence and attribution of human papillomavirus types 52 and 58 in cervical neoplasia worldwide","volume":"9","author":"Chan","year":"2014","journal-title":"PLoS ONE."},{"key":"B33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12985-019-1168-y","article-title":"Identification of variants and therapeutic epitopes in HPV-33\/HPV-58 E6 and E7 in Southwest China","volume":"16","author":"He","year":"2019","journal-title":"Virol J."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.840879\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T07:32:59Z","timestamp":1653463979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.840879\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":33,"alternative-id":["10.3389\/fpubh.2022.840879"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.840879","relation":{},"ISSN":["2296-2565"],"issn-type":[{"type":"electronic","value":"2296-2565"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"article-number":"840879"}}